All over the globe, medical researchers are racing to find a vaccine and treatment for COVID-19. At the same time, government and business leaders are making tough decisions around public health and economic pressures. The fight against COVID-19 will be long and hard-won, and while we work toward a vaccine and therapies, one of our greatest weapons in that fight is data. Data to identify the right combination of molecules and to show effectiveness in the real world. Data to effectively model what-if scenarios for when and how to reopen for business.
We are in this fight together, and data is the connective tissue helping us harness insights for intelligent decision-making. Our health care providers, researchers, governments and business leaders need high-quality, real-time data in order to make informed decisions around policy, potential treatment, public health guidance and employee safety. Complete, accurate and up-to-date information is more critical than ever. And progress is being made as more data sets are made public and companies of all sizes and types have jumped into brainstorm solutions. Vaccine candidates have already been identified at an unprecedented pace and preliminary clinical trials for therapies are underway.
However, this pandemic has made it abundantly clear that many organizations—including government agencies—have not invested enough in their data and technology. The Foundations for Evidence-Based Policymaking Act of 2018 dictated that each agency develop and maintain a comprehensive data inventory and designate a chief data officer. But the Centers for Disease Control and Prevention and several other agencies have left this pivotal role vacant. In essence, the data troops—the data scientists, data engineers and software developers at those agencies—are fighting the battle without a general.
We need CDOs ..
Support the originator by clicking the read the rest link below.
